Dergiler / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 1

The Usefulness of Papanicolaou Test in the Cytomorphological Evaluation of Squamous Cell Abnormalities of the Cervix

Sayfa
96–98
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This screening test can detect abnormal cervical cells before they turn into malignant neoplasm or can be used as a good screening method to detect the earliest signs of carcinogenesis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Papanicolaou or Pap test as a screening method is a suitable method in the prevention of cervical cancer.
📊
Temel Bulgular & Veri:The aim of the present study was to detect the prevalence of various cervical cytology results in the squamous epithelial tissue of the endocervix and endometrium in women, aged 18–70 years, according to the 2014 Bethesda system.
💡
Sonuç & Katkı:This screening test can detect abnormal cervical cells before they turn into malignant neoplasm or can be used as a good screening method to detect the earliest signs of carcinogenesis.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Papanicolaou or Pap test as a screening method is a suitable method in the prevention of cervical cancer. The aim of the present study was to detect the prevalence of various cervical cytology results in the squamous epithelial tissue of the endocervix and endometrium in women, aged 18–70 years, according to the 2014 Bethesda system. This was a hospital-based cross-sectional study conducted on 16,790 Pap smears prepared from women aged 18–70 years between January 2017 and December 2017. The evaluation of the results is hospital based and not the whole country. Diagnosis of atypical squamous cells of undetermined significance was made in 72 (12%) cases. Atypical squamous cells as a HSIL was seen in 36 (6%) cases, human papillomavirus infection in 26 (4%) cases, low-grade squamous intraepithelial lesion as a CIN 1 in 27 (5%) cases and as a CIN 2 in 13 (2%) cases, and high-grade squamous intraepithelial lesion (HGSIL or HSIL) or CIN 3 in 5 (1%) cases. The prevalence of various epithelial abnormalities as glandular epithelial cell abnormalities was determined in 20% of women (119 cases), and it was 50% (298 cases) in other abnormalities. According to these results (high prevalence of epithelial cell abnormalities in cervical smears due to I–XII), Pap test as a screening method should begin at the age of 18 years. This screening test can detect abnormal cervical cells before they turn into malignant neoplasm or can be used as a good screening method to detect the earliest signs of carcinogenesis.

🔖

Bu Makaleye Atıf Yap

BOGDANOVSKA, L., VELICKOVA, N. (2019). The Usefulness of Papanicolaou Test in the Cytomorphological Evaluation of Squamous Cell Abnormalities of the Cervix. Erciyes Medical Journal, Cilt: 41 - Sayı: 1, 96–98. https://ajindex.com/articles/223455

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Štemberger C, Seili-Bekafigo I. Molek Klinička citologija. Clinical cytology. Medicina Fluminensis 2016; 52(3): 301–13. [CrossRef] Pranab D. Case-Based Approach in Fine Needle Aspiration Cytology. London: Jaypee; 2016. Pranab D. Case Based Approach in Exfoliative Cytolog. London: Jaypee; 2017.
  2. Gray W, Kocjan G. Diagnostic Cytopathology, 3rd edition. London: Churchill Livingstone; 2010. [CrossRef] Nandwani R, Totade S, Murali G. Cytomorphological evaluation of squamous cell abnormalities observed on cervical smears in government medical college, Jabalpur, India: a five year study. Int J Res Med Sci 2016; 4(3): 794–9. [CrossRef] ICO/IARC Information Centre on HPV and Cancer Macedonia, TFYR Human Papillomavirus and Related Cancers, Fact Sheet. 2017. Nayar R. Wilbur D. The Bethesda System for Reporting Cervical Cytology: A Historical Perspective. Acta Cytol 2017; 61(4-5): 359–72. Raju K. Evolution of Pap Stain. Biomedical Research and Therapy 2016; 3(2): 490–500. [CrossRef] Nayar R. Wilbur D. The Pap Test and Bethesda 2014. Acta Cytologica 2015; 59: 121–32. [CrossRef]